version no pmc-prop-is-scanned-article no pmc-prop-preprint no pmc-prop-in-epmc yes pmc-license-ref CC BY-NC issue-copyright-statement © Springer Healthcare Ltd., part of Springer Nature 2024 Key Summary Points Introduction The advent of a new ultrashort-acting benzodiazepine, remimazolam, is a highly significant development in the field of sedation for gastrointestinal endoscopy procedures [ 1 ].
← all excerpts
Transcutaneous Electrical Acupoint Stimulation Combined with Moderate Sedation of Remimazolam Tosilate in Gastrointestinal Endoscopy: A Prospective, Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
1
—
—